None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: >18 years old Written informed consent Documented atrial fibrillation during admission CHA2DS2-VASc score =1 (male) or =2 (female) Documented sinus rhythm on discharge and outpatient follow-up
Exclusion criteria
Exclusion criteria: With conflict of interest Unable to provide informed consent Diagnosis of atrial fibrillation before admission History of anti-arrhythmic treatment, intervention, or surgery before admission Documented atrial fibrillation after discharge (before randomization) Cognitive dysfunction Skin allergy reaction to the patch monitoring Life expectancy < 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of newly diagnosed atrial fibrillation and flutter | — |
Secondary
| Measure | Time frame |
|---|---|
| diagnosis rate of paroxysmal supraventricular tachycardia;diagnosis rate of ventricular tachycardia;diagnosis rate of bradycardia arrhythmia;utilization of anticoagulants;Atrial fibrillation cardioversion treatment rate;major clinical event (death, MI, infarction, re-hospitalization) | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center